Close Menu

NEW YORK (GenomeWeb) – Geneseq Biosciences and Australian Clinical Labs today announced a partnership to commercialize a noninvasive melanoma test.

The partners will offer the blood-based test, called Melaseq, which was developed by Geneseq for detecting melanoma signatures. Tissue samples can also be used for Melaseq, they said.  

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.